Healthcare & Life Sciences
Sera Prognostics
Salt Lake City, United Statessera.com
Sera Prognostics is a series c plus startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2014
Founded
1
Investors
About Sera Prognostics
Sera Prognostics is a company founded in 2014 headquartered in Salt Lake City, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Sera Prognostics develops the PreTRM Test, a blood test that predicts an individual's risk of spontaneous preterm delivery in pregnancy. It sells the test to healthcare providers, payers and employers.
Explore Sera Prognostics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.